Ceribell (CBLL) Gross Margin (2023 - 2026)

Ceribell (CBLL) posted Gross Margin of 87.27% for Q1 2026, little changed on a QoQ basis from 87.33% in Q4 2025, and down 61.0% year-over-year from 223.78% in Q1 2025.

Ceribell (CBLL) Gross Margin (2023 - 2026) Analysis & Trends

Ceribell's Gross Margin history runs 4 years deep, the most recent figure standing at 87.27% for Q1 2026.

  • Quarterly Gross Margin fell 61.0% year-over-year to 87.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 87.72% (up 47.0% YoY) and the FY2025 annual result came in at 87.89%, up 117.0% from the prior year.
  • Gross Margin was 87.27% for Q1 2026 at Ceribell, roughly flat from 87.33% in the prior quarter.
  • Across five years, Gross Margin topped out at 88.28% in Q3 2025 and bottomed at 83.77% in Q3 2023.
  • A 4-year average of 86.71% and a median of 87.3% in 2024 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2024 — Gross Margin surged 353 bps — and 2026, when it slumped 61 bps.
  • Ceribell's Gross Margin stood at 84.65% in 2023, then advanced by 3 bps to 87.61% in 2024, then fell by 0 bps to 87.33% in 2025, then retreated by 0 bps to 87.27% in 2026.
  • Business Quant data shows CBLL's Gross Margin at 87.27% in Q1 2026, 87.33% in Q4 2025, and 88.28% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 56.20%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 63.29%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 65.35%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 78.01%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 62.95%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 38.53%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 45.22%
10 Ceribell 677.56 Mn 536.38 Mn 23.12 Mn 87.27%

Historic Data

Download Data
DateValue
Mar 31, 2026 87.27%
Dec 31, 2025 87.33%
Sep 30, 2025 88.28%
Jun 30, 2025 88.13%
Mar 31, 2025 87.88%
Dec 31, 2024 87.61%
Sep 30, 2024 87.30%
Jun 30, 2024 85.92%
Mar 31, 2024 85.71%
Dec 31, 2023 84.65%
Sep 30, 2023 83.77%